CD45 is a glycoprotein expressed in all lymphohemopoietic cells. Its expression increases during B-lymphocyte ontogeny. Few data are available about CD45 expression in the various types of low-grade B-cell non-Hodgkin's lymphomas (NHL). Low levels of CD45 have been reported in pathologic lymphocytes
DNA content of leukaemic cells in non-Hodgkin's lymphomas of low-grade malignancy
✍ Scribed by D�llmann, Jochen ;Wulfhekel, Uwe ;Linden, Walfried A. ;Beck, Hans-Peter ;Hausmann, Kurt
- Publisher
- Springer-Verlag
- Year
- 1980
- Weight
- 940 KB
- Volume
- 41
- Category
- Article
- ISSN
- 1432-0584
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
From 1981 to 1984 a randomized clinical trial was conducted to evaluate the role of doxorubicin in low grade malignancy non-Hodgkin's lymphoma (NHL). One hundred and thirteen patients were treated by an induction regimen including cyclophosphamide 400 mg/m2 day I and 8, vincristine 1.4 mg/m2 day 1 a
In a previous study, we were able to demonstrate that the differentiation of low-grade non-Hodgkin's lymphomas (NHLs) using digital image analysis of touch imprints obtained from native tumor tissue is feasible. The availability of touch imprints in routine diagnostics, however, is restricted. There
## Abstract Malignant and non‐neoplastic cells in 38 cases of highly malignant non‐Hodgkin lymphomas: 3 centrocytic anaplastic, 18 centroblastic, 13 immunoblastic and 4 lymphoblastic (according to the Kiel classification) were immunophenotyped in cryosections and cell suspensions by means of monocl
In this prospective study, we correlated cytological grading and clinical follow-up of non-Hodgkin's lymphomas (NHL) with DNA flow cytometry (FCM) data from fine-needle aspiration biopsy (FNAB) material. FNAB was performed from 34 successive cases of NHL, and the aspirated material was analyzed by D